Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P1ID
|
|||
| Former ID |
DND000028
|
|||
| Drug Name |
MTRX-1011A
|
|||
| Synonyms |
Anti-CD4 mAb, Roche anti-CD4 mAb, Tolerx-2 MTRX-1011A (IV) MTRX-1011A (SC) MTRX-1011A MTRX-1011A (IV), MTRX-1011A (SC) RG-7424, RG-7424 (IV) RG-7424 (SC), RG-7424 RG-7424 (IV), RG-7424 (SC)
Click to Show/Hide
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1 | [1] | |
| Company |
Tolerx
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00718588) A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.